News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Naveen Pemmaraju: Bromodomain and PLX51107 with Azacitidine in Patients with R/R Myeloid Malignancies
Naveen Pemmaraju/mdanderson.org
Mar 11, 2025, 08:03

Naveen Pemmaraju: Bromodomain and PLX51107 with Azacitidine in Patients with R/R Myeloid Malignancies

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, shared a paper he and his colleagues authored on X:

“Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies.”

Authors: Jayastu Senapati et al.

Naveen pemmaraju

cancer Courtney D. DiNardo Darla Miller Elias Jabbour Farhad Ravandi Gautam Borthakur Ghayas C. Issa Guillermo Garcia-Manero Jan Burger Jayastu Senapati Joseph D. Khoury Kapil N. Bhalla Koji Sasaki Lucia Masarova Marina Konopleva Nathaniel R. Wilson Naval Daver Naveen Pemmaraju Nicholas J. Short Nitin Jain OncoDaily Oncology Sherry Pierce Tapan Kadia Warren C. Fiskus Wei Qiao Yesid Alvarado
Special Coverage
Insight
May 6, 2025, 03:29
Yüksel Ürün: Put Patients First: Tailor to Comorbidities, Life Expectancy and Access
Oncolibrary
May 6, 2025, 03:25
Ablation Therapy for Cancer: A Minimally Invasive Treatment Option
Positive
May 6, 2025, 03:20
Aren Karapetyan: Congratulations to Favre-Finn Corrine on receiving the Klaas Breur Award at ESTRO 2025
Blog
May 6, 2025, 03:09
Razelle Kurzrock: So proud of our ETRC group and SWOG
Opinion
May 6, 2025, 02:57
ATOMIC Trial (Alliance A021502): Evaluating Atezolizumab in Adjuvant Treatment of MSI-H/dMMR Stage III Colon Cancer
Opinion
May 6, 2025, 02:55
VERIFY Trial: Phase 3 Results of Rusfertide in Polycythemia Vera
Blog
May 6, 2025, 01:34
Gerry Hanna: First study to show that hippocampus avoidance during WBRT may reduce depression rates
Blog
May 6, 2025, 01:21
Felipe Couñago: First RAPID-RT analysis at ESTRO25
Blog
May 6, 2025, 00:26
Ane Appelt: Amazing work by Max Tanaka from NKI at ESTRO25
Blog
May 5, 2025, 23:22
Giulio Francolini: Wonderful morning session about management of BCR in prostate cancer at ESTRO 2025
Blog
May 5, 2025, 17:25
Alizée Camps Maléa Highlights EMBRACE II Cervix Cancer Study at ESTRO25
Blog
May 5, 2025, 16:58
Gian Marco Petrianni: The ESTRO Re-irradiation Focus Group is born